Medifast Q4 Sales Up 2% To $62.5 Million

Medifast, Inc. (MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the fourth quarter and full year ended December 31, 2016.
“2016 was a year of strong execution reflecting our continued disciplined approach to effectively managing our business. We grew our revenue for the first time since 2013, increased our profitability year-over-year, and raised our quarterly dividend for 2017, all of which supported a strong return for shareholders in 2016,” said Daniel R. Chard, Medifast’s Chief Executive Officer.
“At the same time, we embarked on an exciting business evolution process to more aggressively pursue growth strategies. Going forward, we believe we are well positioned to achieve our operational and financial objectives.”
Fourth Quarter 2016 Results
Results from Continuing Operations
Income from continuing


Leave a Reply

Your email address will not be published. Required fields are marked *